Clinical Trial Update: Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of adding dapagliflozin to ongoing metformin and evogliptin in adults with Type 2 diabetes and inadequate glycem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Evogliptin (evogliptin)
• metformin (metformin)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED